✦ LIBER ✦

IA-2 antibodies – a sensitive marker of IDDM with clinical onset in childhood and adolescence

✍ Scribed by K. Savola; E. Bonifacio; E. Sabbah; P. Kulmala; P. Vähäsalo; J. Karjalainen; E. Tuomilehto-Wolf; J. Meriläinen; H. K. Åkerblom; M. Knip; Childhood Diabetes Finland Study Group

Publisher: Springer
Year: 1998
Tongue: English
Weight: 265 KB
Volume: 41
Category: Article
ISSN: 0012-186X
DOI: 10.1007/s001250050925

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combined screening for autoantibodies to

Combined screening for autoantibodies to IA-2 and antibodies to glutamic acid decarboxylase in first degree relatives of patients with IDDM

✍ J. Seissler; N. G. Morgenthaler; P. Achenbach; E. F. Lampeter; D. Glawe; M. Payt 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 244 KB

Diverging evolution of anti-GAD and anti

Diverging evolution of anti-GAD and anti-IA-2 antibodies in long-standing diabetes mellitus as a function of age at onset: no association with complications

✍ Hermitte, L.; Atlan-Gepner, C.; Mattei, C.; Dufayet, D.; Jannot, M.F.; Christofi 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 2 views

## Glutamic acid decarboxylase autoantibodies (GAD -A ) and tyrosine phosphatase IA-2 autoantibodies (IA2-A) were measured in sera of 50 recently diagnosed (Ͻ6 wk, 33 % younger than 15 yr), 19 short-term (1 to 9 yr, 35 % with onset age below 15 yr) and 89 long-standing diabetic patients (Ͼ10 yr